Table 1.
The Clinical Profile of the Study Subjects
| S. no. | Subject-ID | Accession no. | Date of visit | Age | Gender | CD4 count (cells/μl of plasma) | Plasma viral load (copies/ml of plasma) |
|---|---|---|---|---|---|---|---|
| 1 | INDO-SA-NLR2001 | KM496583-84 | 26-Sep-11 | 23 | F | 608 | 25,149 |
| 2 | INDO-SA-NLR2002 | KM496585-86 | 26-Sep-11 | 32 | F | 589 | 26,186 |
| 3 | INDO-SA-NLR2004 | KM496587-88 | 26-Sep-11 | 43 | F | 1,012 | 6,070 |
| 4 | INDO-SA-NLR2005 | KM496589-91 | 26-Sep-11 | 35 | F | 599 | 5,713 |
| 5 | INDO-SA-NLR2006 | KM496592 | 26-Sep-11 | 46 | F | 659 | 662 |
| 6 | INDO-SA-NLR2007 | KM496593-95 | 26-Sep-11 | 40 | M | 546 | 11,986 |
| 7 | INDO-SA-NLR2008 | KM496596 | 26-Sep-11 | 46 | M | 1,289 | 3,687 |
| 8 | INDO-SA-NLR2010 | KM496597-99 | 26-Sep-11 | 32 | F | 989 | 251 |
| 9 | INDO-SA-NLR2011 | KM496600 | 26-Sep-11 | 28 | F | 582 | 2,704 |
| 10 | INDO-SA-NLR2012 | KM496602 | 28-Sep-11 | 28 | F | 1,087 | 6,070 |
| 11 | INDO-SA-NLR2014 | KM496603-04 | 28-Sep-11 | 55 | M | 766 | 88,645 |
| 12 | INDO-SA-NLR2015 | KM496605 | 28-Sep-11 | 34 | F | 1,019 | 21,108 |
| 13 | INDO-SA-NLR2016 | KM496607-08 | 28-Sep-11 | 29 | F | 631 | 26,363 |
| 14 | INDO-SA-NLR2017 | KM496609-10 | 28-Sep-11 | 39 | M | 581 | 8,972 |
| 15 | INDO-SA-NLR2018 | KM496611-12 | 28-Sep-11 | 35 | F | 825 | 6,493 |
| 16 | INDO-SA-NLR2019 | KM496613 | 28-Sep-11 | 35 | F | 1,085 | 185 |
| 17 | INDO-SA-NLR2020 | KM496614-16 | 28-Sep-11 | 38 | M | 570 | 70,025 |
| 18 | INDO-SA-NLR2022 | KM496617 | 28-Sep-11 | 38 | M | 1,489 | <150 |
| 19 | INDO-SA-NLR2024 | KM496618 | 14-Oct-11 | 30 | F | 984 | 340 |
| 20 | INDO-SA-NLR2025 | KM496619-20 | 14-Oct-11 | 30 | M | 500 | 3,423 |
| 21 | INDO-SA-NLR2026 | KM496621 | 14-Oct-11 | 18 | M | 1,015 | 8,733 |
| 22 | INDO-SA-NLR2028 | KM496622-23 | 14-Oct-11 | 34 | F | 711 | 24,480 |
| 23 | INDO-SA-NLR2032 | KM496624-25 | 14-Oct-11 | 45 | M | 671 | 9,468 |
| 24 | INDO-SA-NLR2036 | KM496626-28 | 14-Oct-11 | 27 | M | 860 | 3,332 |
| 25 | INDO-SA-NLR2037 | KM496629 | 14-Oct-11 | 29 | M | 732 | 1,505 |
| 26 | INDO-SA-NLR2038 | KM496630 | 31-Oct-11 | 33 | M | 669 | 26,542 |
| 27 | INDO-SA-NLR2039 | KM496631-32 | 31-Oct-11 | 47 | M | 925 | 45,63,295 |
| 28 | INDO-SA-NLR2041 | KM496633 | 31-Oct-11 | 45 | M | 888 | 56,445 |
| 29 | INDO-SA-NLR2043 | KM496634 | 6-Sep-13 | 49 | M | 446 | — |
| 30 | INDO-SA-NLR2044 | KM496635 | 13-Sep-13 | 35 | M | 596 | — |
| 31 | INDO-SA-NLR2049 | KM496636 | 23-Oct-13 | 30 | M | 475 | — |
| 32 | INDO-SA-NLR2050 | KM496637 | 11-Nov-13 | 48 | M | 1,047 | — |
| 33 | INDO-SA-NLR2051 | KM496638 | 11-Nov-13 | 35 | F | 504 | — |
| 34 | INDO-SA-NLR2053 | KM496639 | 11-Nov-13 | 29 | F | 390 | — |
| 35 | INDO-SA-NLR2054 | KM496640 | 11-Nov-13 | 30 | F | 597 | — |
| 36 | INDO-SA-NLR2055 | KM496641 | 11-Nov-13 | 42 | F | 495 | — |
| 37 | INDO-SA-NLR2056 | KM496642 | 11-Nov-13 | 29 | F | 360 | — |
| 38 | INDO-SA-NLR2058 | KM496643 | 11-Nov-13 | 27 | M | 980 | — |
| 39 | INDO-SA-NLR2060 | KM496644 | 11-Nov-13 | 27 | M | 386 | — |
| 40 | INDO-SA-NLR2061 | KM496645 | 11-Nov-13 | 50 | M | 338 | — |
| 41 | INDO-SA-NLR2062 | KM496646 | 11-Nov-13 | 50 | F | 700 | — |
| 42 | INDO-SA-NLR2063 | KM496647 | 11-Nov-13 | 32 | F | 812 | — |
| 43 | INDO-SA-NLR2064 | KM496648 | 11-Nov-13 | 35 | F | 516 | — |
| 44 | INDO-SA-NLR2066 | KM496649 | 11-Nov-13 | 28 | F | — | — |
| 45 | INDO-SA-NLR2067 | KM496650 | 11-Nov-13 | 32 | F | — | — |
| 46 | INDO-SA-NLR2068 | KM496651 | 11-Nov-13 | 34 | M | 1,300 | — |
| 47 | INDO-SA-NLR2072 | KM496652 | 14-Nov-13 | 34 | M | 466 | — |
| 48 | INDO-SA-NLR2073 | KM496653 | 14-Nov-13 | 32 | M | 700 | — |
| 49 | INDO-SA-NLR2076 | KM496654 | 14-Nov-13 | 45 | M | — | — |
| 50 | INDO-SA-NLR2078 | KM496655 | 14-Nov-13 | — | F | — | — |
| 51 | INDO-SA-NLR2080 | KM496656 | 14-Nov-13 | 35 | F | — | — |
| 52 | INDO-SA-NLR2081 | KM496657 | 15-Nov-13 | 30 | F | — | — |
| 53 | INDO-SA-NLR2082 | KM496658 | 14-Nov-13 | — | M | — | — |
Date of visit refers to the enrollment (baseline) time point. The CD4 count and plasma viral load values were determined at the time of visit and not available for some of the patients. The GenBank accession numbers of the Tat sequences are presented.